GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Change In Receivables

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JiangXi Tianxin Pharmaceutical Co Change In Receivables?

JiangXi Tianxin Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means JiangXi Tianxin Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

JiangXi Tianxin Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥7 Mil. It means JiangXi Tianxin Pharmaceutical Co's Accounts Receivable declined by ¥7 Mil from Dec. 2022 to Dec. 2023 .

JiangXi Tianxin Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥265 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. JiangXi Tianxin Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 48.90.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. JiangXi Tianxin Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥1,901 Mil.


JiangXi Tianxin Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for JiangXi Tianxin Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JiangXi Tianxin Pharmaceutical Co Change In Receivables Chart

JiangXi Tianxin Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial 129.13 8.61 -167.58 63.92 7.15

JiangXi Tianxin Pharmaceutical Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

JiangXi Tianxin Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JiangXi Tianxin Pharmaceutical Co  (SHSE:603235) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

JiangXi Tianxin Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=265.009/494.498*91
=48.90

2. In Ben Graham's calculation of liquidation value, JiangXi Tianxin Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

JiangXi Tianxin Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2379.813-895.048+0.75 * 265.009+0.5 * 434.43
=1,901

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JiangXi Tianxin Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of JiangXi Tianxin Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description

Traded in Other Exchanges
N/A
Address
Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Headlines

No Headlines